Belantamab Biosimilar - Research Grade
Product Specifications
Background
RUO belantamab mafodotin. Belantamab mafodotin is a medication for the treatment of relapsed and refractory multiple myeloma.
Product Name Alternative
GSK2857916, B-cell maturation antigen, CD269
UniProt
Q02223
Reactivity
Human
Target
BCMA
Isotype
IgG1
Sequence
https://www.imgt.org/mAb-DB/
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Buffer
ICH3002
References & Citations
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Specificity
Detects human BCMA. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Belantamab mafodotin.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO) : it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Isotype Control
Bulk Human IgG1 Isotype Control (IB1) [ICH2254]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
